GovChime
Notice ID: 77dc7257813deb2cd705396682f69208Special Notice

A--Performance of Good Clinical Practices (GCP) Compliant Clinical Trials of a Freeze Dried Plasma (FDP) Product of Support Efforts to Obtain Food and Drug Administration (FDA) Licensure

Archived on June 13, 2015. Full description on SAM.gov.

Overview

Posted
June 13, 2014
Notice type
Special Notice
NAICS
541711: Classification Not Available

Notice details

PSC
A: RESEARCH AND DEVELOPMENT
Last updated
Dec 4, 2025

Identifiers

Solicitation number
W81XWH14R0059
Notice ID
77dc7257813deb2cd705396682f69208

Description

The US Army has a requirement to develop and license a FDP product in accordance with the Department of Defense (DoD) Acquisition System, FDA regulations and guidelines, and industry best practices. In direct support of the US Army product development effort, the Government is seeking to obtain clinical trial and regulatory support in the performance of GCP compliant clinical trials of a FDP product (Pre-clinical, Phase I, Phase II and Phase III). The acquisition strategy for the FDP program will utilize a combination of a Cooperative Research and Development Agreement (CRADA) for manufacturing (CRADA partner will fund the manufacturing development) and a contract (subject of this solicitation notice) for conduct of clinical trials and regulatory/technical support. The CRADA partner will supply all clinical trial material for conduct of the clinical trials. The U.S. Army Office of The Surgeon General (OTSG) will be the regulatory sponsor of record for the Investigational New Drug (IND) application, but ultimately the CRADA partner will submit and manage the Biologics License Application (BLA).

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Shannyn Scassero, 301-619-2640 US Army Medical Research Acquisition Activity

Documents

No documents available.

Lifecycle

Solicitation:W81XWH14R0059
  1. Special NoticeCurrentJun 13, 2014

    A--Performance of Good Clinical Practices (GCP) Compliant Clinical Trials of a Freeze Dried Plasma (FDP) Product of Support Efforts to Obtain Food and Drug Administration (FDA) Licensure

    Notice 77dc7257813deb2cd705396682f69208 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

W81XWH14R0059

Archive Date

Jun 13, 2015